+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Clinical Microbiology Market - Global Forecast 2026-2032- Product Image
Clinical Microbiology Market - Global Forecast 2026-2032- Product Image
Sale

Clinical Microbiology Market - Global Forecast 2026-2032

  • Report

  • 190 Pages
  • August 2026
  • Region: Global
  • 360iResearch™
  • ID: 5337233
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Clinical Microbiology Market is projected to reach USD 5.67 Billion in 2026. It is expected to continue growing at a CAGR of 8.01%, reaching USD 9.03 Billion by 2032.

Clinical microbiology is moving from culture-centered confirmation toward integrated infectious disease diagnostics that combine phenotypic testing, molecular assays, mass spectrometry, syndromic panels, antimicrobial susceptibility testing, and digital epidemiology. Demand is supported by the persistent burden of healthcare-associated infections, tuberculosis, sepsis, sexually transmitted infections, respiratory viruses, and antimicrobial resistance.

The market is shaped by evidence-based clinical needs: faster pathogen identification, earlier targeted therapy, improved infection prevention, and stronger public health surveillance. The World Health Organization recognizes antimicrobial resistance as a major global health threat, with a 2019 global analysis estimating 1.27 million deaths directly attributable to bacterial AMR, underscoring the strategic importance of clinical microbiology laboratories.

Transformative Shifts in Clinical Microbiology

The clinical microbiology landscape is being transformed by automation, rapid molecular diagnostics, MALDI-TOF mass spectrometry, next-generation sequencing, point-of-care testing, and cloud-connected laboratory information systems. These technologies are reducing turnaround time, expanding test menus, and improving laboratory productivity amid documented laboratory workforce constraints in many health systems.

Hospitals and reference laboratories are also shifting from isolated test results to decision-support-enabled diagnostics. Stewardship programs increasingly depend on rapid organism identification and susceptibility data to guide antimicrobial selection, while infection control teams use microbiology data to detect outbreaks, monitor resistance patterns, and reduce preventable transmission.

Cumulative Impact of Artificial Intelligence

Artificial intelligence is increasingly used to support colony recognition, Gram stain interpretation, digital plate reading, antimicrobial resistance prediction, workflow triage, and epidemiological signal detection. AI does not replace clinical microbiologists; it strengthens standardization, reduces repetitive review, and helps prioritize complex or urgent cases.

The cumulative impact is most visible where AI is combined with automation, electronic health records, and laboratory information systems. Validated algorithms can accelerate result interpretation and support antimicrobial stewardship, but adoption depends on transparent validation, cybersecurity, regulatory compliance, bias monitoring, and clinician trust.

Key Regional Insights Across Global Clinical Microbiology

North America remains a high-adoption region for advanced clinical microbiology, driven by hospital consolidation, strong reference laboratory networks, antimicrobial stewardship requirements, and sustained investment in molecular diagnostics. In the United States, CDC surveillance continues to identify antimicrobial resistance and healthcare-associated infections as major patient-safety priorities, while Canada’s public health system supports national laboratory coordination. Europe benefits from structured surveillance systems, national AMR action plans, and broad use of quality-assured laboratory standards, while European Union initiatives support cross-border preparedness, medical device oversight, and data interoperability.

Asia-Pacific is expanding its clinical microbiology capabilities as China, India, Japan, South Korea, Australia, and ASEAN health systems invest in hospital capacity, tuberculosis diagnostics, respiratory testing, and AMR surveillance. Latin America is improving access through public-private laboratory networks, with Brazil and Mexico playing important roles in infectious disease programs and hospital-based diagnostics. The Middle East, especially GCC countries, is modernizing tertiary care laboratories through accreditation, digital health initiatives, and specialized hospital infrastructure, while Africa’s progress is closely linked to tuberculosis, HIV, malaria, outbreak preparedness, genomic surveillance, and externally supported laboratory strengthening programs.

Key Group Insights for Clinical Microbiology Demand

ASEAN countries are prioritizing infectious disease preparedness, laboratory capacity, and AMR surveillance after repeated exposure to respiratory outbreaks, dengue, tuberculosis, and endemic tropical diseases. The GCC is investing in advanced hospital infrastructure, accreditation, and digital health systems that support high-complexity microbiology testing, rapid molecular diagnostics, and centralized laboratory models.

The European Union provides a structured environment for diagnostics through coordinated surveillance, medical device regulation, and public health agencies. BRICS countries represent large-volume demand across tuberculosis, sepsis, respiratory infections, sexually transmitted infections, and AMR, though access, reimbursement, and laboratory quality systems vary widely. G7 countries drive premium technology adoption, clinical evidence generation, and stewardship-oriented diagnostic policies, while NATO members increasingly view diagnostic resilience, biosecurity, and outbreak response capacity as part of health security readiness.

Key Country Insights in Clinical Microbiology

The United States leads in advanced microbiology adoption through major reference laboratories, hospital networks, FDA-regulated diagnostics, and stewardship-driven testing. Canada emphasizes public health surveillance, laboratory quality, and equitable access, while Mexico and Brazil continue expanding diagnostic capacity in urban hospital systems, national disease programs, and infectious disease reference networks. In Europe, the United Kingdom, Germany, France, Italy, and Spain combine mature hospital infrastructure with AMR policy priorities, laboratory accreditation, and respiratory infection preparedness, while Russia maintains demand across tuberculosis, respiratory disease, antimicrobial resistance monitoring, and centralized public health testing.

China and India are central to global clinical microbiology growth because of population scale, hospital expansion, tuberculosis burden, respiratory pathogen surveillance, and rising demand for molecular diagnostics. Japan, South Korea, and Australia show strong adoption of automated, quality-focused laboratory systems, with Japan emphasizing precision diagnostics, South Korea benefiting from advanced digital healthcare infrastructure, and Australia supported by robust public health laboratory networks. Across all countries, reimbursement, regulatory pathways, procurement models, laboratory accreditation, and workforce availability determine the speed of implementation.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize platforms that shorten time to clinically actionable results, integrate with laboratory information systems, and support antimicrobial stewardship. Product strategies should balance high-throughput automation for reference laboratories with cost-effective, decentralized testing for hospitals, outpatient settings, and emerging health systems.

Organizations should invest in clinical validation, cybersecurity, interoperability, quality management, and post-market evidence. Partnerships with hospitals, public health agencies, and academic centers can improve adoption, while training programs, workflow consulting, and service models help customers address microbiology workforce constraints and maintain consistent quality standards.

Research Methodology

This executive summary is based on secondary research from public health agencies, peer-reviewed literature, regulatory guidance, clinical laboratory standards, and recognized epidemiological datasets. Sources commonly used for clinical microbiology assessment include WHO, CDC, ECDC, national surveillance programs, and published AMR and infectious disease burden studies.

Findings are synthesized through market triangulation, technology assessment, regional policy review, and demand-side analysis across hospitals, reference laboratories, academic centers, and public health laboratories. Emphasis is placed on verified trends, documented disease burden, regulatory developments, laboratory quality standards, and observable adoption patterns rather than unsupported projections.

Conclusion

Clinical microbiology is becoming a strategic pillar of infectious disease management, public health security, and antimicrobial stewardship. The sector’s value increasingly comes from speed, accuracy, workflow efficiency, and the ability to convert laboratory data into treatment, infection control, and surveillance intelligence.

Organizations that combine validated diagnostics, automation, AI-enabled decision support, and strong regional access strategies will be best positioned. As AMR, emerging pathogens, tuberculosis, respiratory infections, and healthcare-associated infections remain persistent risks, investment in modern clinical microbiology infrastructure will remain a public health and commercial priority.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. New Revenue Opportunities
3.5. Next-Generation Business Models
3.6. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Clinical Microbiology Market, by Product Type
7.1. Introduction
7.2. Instruments
7.2.1. Microscopes
7.2.2. Incubators
7.2.3. Anaerobic Chambers / Workstations
7.2.4. Autoclaves
7.2.5. Centrifuges
7.3. Reagents & Kits
7.4. Services
7.4.1. Consulting Services
7.4.2. Maintenance & Support
7.5. Software
7.5.1. LIS/LIMS Integration
7.5.2. Middleware
7.5.3. Digital Plate Reading
7.5.4. Data Analytics
8. Clinical Microbiology Market, by Technology
8.1. Introduction
8.2. Immunoassays
8.2.1. CLIA
8.2.2. ELISA
8.2.3. FIA
8.3. MALDI-TOF
8.4. Microarrays
8.5. PCR
8.6. Sequencing
8.6.1. NGS
8.6.2. Sanger Sequencing
9. Clinical Microbiology Market, by Test Type
9.1. Introduction
9.2. Qualitative
9.3. Quantitative
10. Clinical Microbiology Market, by Specimen Type
10.1. Introduction
10.2. Blood
10.2.1. Plasma
10.2.2. Serum
10.2.3. Whole Blood
10.3. Respiratory
10.4. Tissue
10.5. Urine
11. Clinical Microbiology Market, by Level of Automation
11.1. Introduction
11.2. Manual
11.3. Semi-Automated
11.4. Fully-Automated
12. Clinical Microbiology Market, by Application
12.1. Introduction
12.2. Antimicrobial Resistance Testing
12.3. Blood Screening
12.4. Genotyping
12.5. Infectious Diseases
12.5.1. Bacterial Infections
12.5.2. Fungal Infections
12.5.3. Parasitic Infections
12.5.4. Viral Infections
13. Clinical Microbiology Market, by End User
13.1. Introduction
13.2. Academic Research Institutes
13.3. Hospitals & Clinics
13.4. Pharma & Biotech Companies
13.5. Reference Laboratories
14. Clinical Microbiology Market, by Region
14.1. Asia-Pacific
14.2. Europe
14.3. North America
14.4. Latin America
14.5. Africa
14.6. Middle East
15. Clinical Microbiology Market, by Group
15.1. NATO
15.2. G7
15.3. BRICS
15.4. European Union
15.5. ASEAN
15.6. GCC
16. Clinical Microbiology Market, by Country
16.1. China
16.2. United States
16.3. Japan
16.4. India
16.5. Germany
16.6. United Kingdom
16.7. Australia
16.8. France
16.9. South Korea
16.10. Italy
16.11. Canada
16.12. Russia
16.13. Brazil
16.14. Mexico
16.15. Spain
17. Competitive Landscape
17.1. Market Share Analysis, 2025
17.2. FPNV Positioning Matrix, 2025
17.3. Market Concentration Analysis, 2025
17.3.1. Concentration Ratio (CR)
17.3.2. Herfindahl Hirschman Index (HHI)
17.4. Recent Developments & Impact Analysis, 2025
17.5. Product Portfolio Analysis, 2025
17.6. Benchmarking Analysis, 2025
18. Company Profiles
18.1. Abbott Laboratories
18.2. Agilent Technologies, Inc.
18.3. Becton, Dickinson and Company
18.4. Bio-Rad Laboratories, Inc.
18.5. bioMérieux SA
18.6. Bruker Corporation
18.7. COPAN Group
18.8. Danaher Corporation
18.9. DiaSorin S.p.A.
18.10. Eurofins Scientific SE
18.11. F. Hoffmann-La Roche Ltd
18.12. Hardy Diagnostics
18.13. HiMedia Laboratories
18.14. Hologic, Inc.
18.15. Illumina, Inc.
18.16. Luminex Corporation
18.17. Merck KGaA
18.18. Meridian Bioscience
18.19. Ortho Clinical Diagnostics Holdings plc
18.20. PerkinElmer, Inc.
18.21. QIAGEN N.V.
18.22. QuidelOrtho Corporation
18.23. Rapid Micro Biosystems, Inc.
18.24. Seegene Inc.
18.25. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
18.26. Siemens Healthineers AG
18.27. Thermo Fisher Scientific Inc
18.28. Waters Corporation
List of Figures
FIGURE 1. GLOBAL CLINICAL MICROBIOLOGY MARKET, YEARS CONSIDERED FOR THE STUDY
FIGURE 2. GLOBAL CLINICAL MICROBIOLOGY MARKET, RESEARCH DESIGN
FIGURE 3. GLOBAL CLINICAL MICROBIOLOGY MARKET, RESEARCH FRAMEWORK
FIGURE 4. GLOBAL CLINICAL MICROBIOLOGY MARKET, DATA TRIANGULATION
FIGURE 5. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, 2024-2032 (USD MILLION)
FIGURE 6. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2032 (%)
FIGURE 7. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY TECHNOLOGY, 2025 VS 2032 (%)
FIGURE 9. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY TEST TYPE, 2025 VS 2032 (%)
FIGURE 11. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY TEST TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2025 VS 2032 (%)
FIGURE 13. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 14. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY LEVEL OF AUTOMATION, 2025 VS 2032 (%)
FIGURE 15. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY LEVEL OF AUTOMATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 16. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2025 VS 2032 (%)
FIGURE 17. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 18. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY END USER, 2025 VS 2032 (%)
FIGURE 19. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 20. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 21. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 22. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 23. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 24. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
FIGURE 25. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 26. GLOBAL CLINICAL MICROBIOLOGY MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 27. GLOBAL CLINICAL MICROBIOLOGY MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025
List of Tables
TABLE 1. GLOBAL CLINICAL MICROBIOLOGY MARKET SEGMENTATION & COVERAGE
TABLE 2. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 3. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 4. GLOBAL INSTRUMENTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 5. GLOBAL INSTRUMENTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 6. GLOBAL INSTRUMENTS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 7. GLOBAL MICROSCOPES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 8. GLOBAL MICROSCOPES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 9. GLOBAL MICROSCOPES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 10. GLOBAL INCUBATORS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 11. GLOBAL INCUBATORS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 12. GLOBAL INCUBATORS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 13. GLOBAL ANAEROBIC CHAMBERS / WORKSTATIONS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 14. GLOBAL ANAEROBIC CHAMBERS / WORKSTATIONS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 15. GLOBAL ANAEROBIC CHAMBERS / WORKSTATIONS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 16. GLOBAL AUTOCLAVES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 17. GLOBAL AUTOCLAVES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 18. GLOBAL AUTOCLAVES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 19. GLOBAL CENTRIFUGES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 20. GLOBAL CENTRIFUGES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 21. GLOBAL CENTRIFUGES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 22. GLOBAL REAGENTS & KITS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 23. GLOBAL REAGENTS & KITS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 24. GLOBAL REAGENTS & KITS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 25. GLOBAL SERVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 26. GLOBAL SERVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 27. GLOBAL SERVICES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 28. GLOBAL CONSULTING SERVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 29. GLOBAL CONSULTING SERVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 30. GLOBAL CONSULTING SERVICES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 31. GLOBAL MAINTENANCE & SUPPORT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 32. GLOBAL MAINTENANCE & SUPPORT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 33. GLOBAL MAINTENANCE & SUPPORT MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 34. GLOBAL SOFTWARE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 35. GLOBAL SOFTWARE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 36. GLOBAL SOFTWARE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 37. GLOBAL LIS/LIMS INTEGRATION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 38. GLOBAL LIS/LIMS INTEGRATION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 39. GLOBAL LIS/LIMS INTEGRATION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 40. GLOBAL MIDDLEWARE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 41. GLOBAL MIDDLEWARE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 42. GLOBAL MIDDLEWARE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 43. GLOBAL DIGITAL PLATE READING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 44. GLOBAL DIGITAL PLATE READING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 45. GLOBAL DIGITAL PLATE READING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 46. GLOBAL DATA ANALYTICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 47. GLOBAL DATA ANALYTICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 48. GLOBAL DATA ANALYTICS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 49. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 50. GLOBAL IMMUNOASSAYS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 51. GLOBAL IMMUNOASSAYS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 52. GLOBAL IMMUNOASSAYS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 53. GLOBAL CLIA MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 54. GLOBAL CLIA MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 55. GLOBAL CLIA MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 56. GLOBAL ELISA MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 57. GLOBAL ELISA MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 58. GLOBAL ELISA MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 59. GLOBAL FIA MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 60. GLOBAL FIA MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 61. GLOBAL FIA MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 62. GLOBAL MALDI-TOF MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 63. GLOBAL MALDI-TOF MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 64. GLOBAL MALDI-TOF MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 65. GLOBAL MICROARRAYS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 66. GLOBAL MICROARRAYS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 67. GLOBAL MICROARRAYS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 68. GLOBAL PCR MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 69. GLOBAL PCR MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 70. GLOBAL PCR MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 71. GLOBAL SEQUENCING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 72. GLOBAL SEQUENCING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 73. GLOBAL SEQUENCING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 74. GLOBAL NGS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 75. GLOBAL NGS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 76. GLOBAL NGS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 77. GLOBAL SANGER SEQUENCING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 78. GLOBAL SANGER SEQUENCING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 79. GLOBAL SANGER SEQUENCING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 80. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 81. GLOBAL QUALITATIVE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 82. GLOBAL QUALITATIVE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 83. GLOBAL QUALITATIVE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 84. GLOBAL QUANTITATIVE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 85. GLOBAL QUANTITATIVE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 86. GLOBAL QUANTITATIVE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 87. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2017-2032 (USD MILLION)
TABLE 88. GLOBAL BLOOD MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 89. GLOBAL BLOOD MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 90. GLOBAL BLOOD MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 91. GLOBAL PLASMA MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 92. GLOBAL PLASMA MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 93. GLOBAL PLASMA MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 94. GLOBAL SERUM MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 95. GLOBAL SERUM MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 96. GLOBAL SERUM MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 97. GLOBAL WHOLE BLOOD MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 98. GLOBAL WHOLE BLOOD MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 99. GLOBAL WHOLE BLOOD MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 100. GLOBAL RESPIRATORY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 101. GLOBAL RESPIRATORY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 102. GLOBAL RESPIRATORY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 103. GLOBAL TISSUE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 104. GLOBAL TISSUE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 105. GLOBAL TISSUE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 106. GLOBAL URINE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 107. GLOBAL URINE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 108. GLOBAL URINE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 109. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY LEVEL OF AUTOMATION, 2017-2032 (USD MILLION)
TABLE 110. GLOBAL MANUAL MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 111. GLOBAL MANUAL MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 112. GLOBAL MANUAL MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 113. GLOBAL SEMI-AUTOMATED MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 114. GLOBAL SEMI-AUTOMATED MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 115. GLOBAL SEMI-AUTOMATED MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 116. GLOBAL FULLY-AUTOMATED MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 117. GLOBAL FULLY-AUTOMATED MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 118. GLOBAL FULLY-AUTOMATED MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 119. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 120. GLOBAL ANTIMICROBIAL RESISTANCE TESTING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 121. GLOBAL ANTIMICROBIAL RESISTANCE TESTING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 122. GLOBAL ANTIMICROBIAL RESISTANCE TESTING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 123. GLOBAL BLOOD SCREENING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 124. GLOBAL BLOOD SCREENING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 125. GLOBAL BLOOD SCREENING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 126. GLOBAL GENOTYPING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 127. GLOBAL GENOTYPING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 128. GLOBAL GENOTYPING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 129. GLOBAL INFECTIOUS DISEASES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 130. GLOBAL INFECTIOUS DISEASES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 131. GLOBAL INFECTIOUS DISEASES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 132. GLOBAL BACTERIAL INFECTIONS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 133. GLOBAL BACTERIAL INFECTIONS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 134. GLOBAL BACTERIAL INFECTIONS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 135. GLOBAL FUNGAL INFECTIONS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 136. GLOBAL FUNGAL INFECTIONS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 137. GLOBAL FUNGAL INFECTIONS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 138. GLOBAL PARASITIC INFECTIONS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 139. GLOBAL PARASITIC INFECTIONS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 140. GLOBAL PARASITIC INFECTIONS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 141. GLOBAL VIRAL INFECTIONS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 142. GLOBAL VIRAL INFECTIONS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 143. GLOBAL VIRAL INFECTIONS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 144. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 145. GLOBAL ACADEMIC RESEARCH INSTITUTES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 146. GLOBAL ACADEMIC RESEARCH INSTITUTES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 147. GLOBAL ACADEMIC RESEARCH INSTITUTES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 148. GLOBAL HOSPITALS & CLINICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 149. GLOBAL HOSPITALS & CLINICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 150. GLOBAL HOSPITALS & CLINICS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 151. GLOBAL PHARMA & BIOTECH COMPANIES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 152. GLOBAL PHARMA & BIOTECH COMPANIES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 153. GLOBAL PHARMA & BIOTECH COMPANIES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 154. GLOBAL REFERENCE LABORATORIES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 155. GLOBAL REFERENCE LABORATORIES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 156. GLOBAL REFERENCE LABORATORIES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 157. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 158. ASIA-PACIFIC CLINICAL MICROBIOLOGY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 159. ASIA-PACIFIC CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 160. ASIA-PACIFIC CLINICAL MICROBIOLOGY MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 161. ASIA-PACIFIC CLINICAL MICROBIOLOGY MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 162. ASIA-PACIFIC CLINICAL MICROBIOLOGY MARKET SIZE, BY SOFTWARE, 2017-2032 (USD MILLION)
TABLE 163. ASIA-PACIFIC CLINICAL MICROBIOLOGY MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 164. ASIA-PACIFIC CLINICAL MICROBIOLOGY MARKET SIZE, BY IMMUNOASSAYS, 2017-2032 (USD MILLION)
TABLE 165. ASIA-PACIFIC CLINICAL MICROBIOLOGY MARKET SIZE, BY SEQUENCING, 2017-2032 (USD MILLION)
TABLE 166. ASIA-PACIFIC CLINICAL MICROBIOLOGY MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 167. ASIA-PACIFIC CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2017-2032 (USD MILLION)
TABLE 168. ASIA-PACIFIC CLINICAL MICROBIOLOGY MARKET SIZE, BY BLOOD, 2017-2032 (USD MILLION)
TABLE 169. ASIA-PACIFIC CLINICAL MICROBIOLOGY MARKET SIZE, BY LEVEL OF AUTOMATION, 2017-2032 (USD MILLION)
TABLE 170. ASIA-PACIFIC CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 171. ASIA-PACIFIC CLINICAL MICROBIOLOGY MARKET SIZE, BY INFECTIOUS DISEASES, 2017-2032 (USD MILLION)
TABLE 172. ASIA-PACIFIC CLINICAL MICROBIOLOGY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 173. EUROPE CLINICAL MICROBIOLOGY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 174. EUROPE CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 175. EUROPE CLINICAL MICROBIOLOGY MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 176. EUROPE CLINICAL MICROBIOLOGY MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 177. EUROPE CLINICAL MICROBIOLOGY MARKET SIZE, BY SOFTWARE, 2017-2032 (USD MILLION)
TABLE 178. EUROPE CLINICAL MICROBIOLOGY MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 179. EUROPE CLINICAL MICROBIOLOGY MARKET SIZE, BY IMMUNOASSAYS, 2017-2032 (USD MILLION)
TABLE 180. EUROPE CLINICAL MICROBIOLOGY MARKET SIZE, BY SEQUENCING, 2017-2032 (USD MILLION)
TABLE 181. EUROPE CLINICAL MICROBIOLOGY MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 182. EUROPE CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2017-2032 (USD MILLION)
TABLE 183. EUROPE CLINICAL MICROBIOLOGY MARKET SIZE, BY BLOOD, 2017-2032 (USD MILLION)
TABLE 184. EUROPE CLINICAL MICROBIOLOGY MARKET SIZE, BY LEVEL OF AUTOMATION, 2017-2032 (USD MILLION)
TABLE 185. EUROPE CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 186. EUROPE CLINICAL MICROBIOLOGY MARKET SIZE, BY INFECTIOUS DISEASES, 2017-2032 (USD MILLION)
TABLE 187. EUROPE CLINICAL MICROBIOLOGY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 188. NORTH AMERICA CLINICAL MICROBIOLOGY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 189. NORTH AMERICA CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 190. NORTH AMERICA CLINICAL MICROBIOLOGY MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 191. NORTH AMERICA CLINICAL MICROBIOLOGY MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 192. NORTH AMERICA CLINICAL MICROBIOLOGY MARKET SIZE, BY SOFTWARE, 2017-2032 (USD MILLION)
TABLE 193. NORTH AMERICA CLINICAL MICROBIOLOGY MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 194. NORTH AMERICA CLINICAL MICROBIOLOGY MARKET SIZE, BY IMMUNOASSAYS, 2017-2032 (USD MILLION)
TABLE 195. NORTH AMERICA CLINICAL MICROBIOLOGY MARKET SIZE, BY SEQUENCING, 2017-2032 (USD MILLION)
TABLE 196. NORTH AMERICA CLINICAL MICROBIOLOGY MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 197. NORTH AMERICA CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2017-2032 (USD MILLION)
TABLE 198. NORTH AMERICA CLINICAL MICROBIOLOGY MARKET SIZE, BY BLOOD, 2017-2032 (USD MILLION)
TABLE 199. NORTH AMERICA CLINICAL MICROBIOLOGY MARKET SIZE, BY LEVEL OF AUTOMATION, 2017-2032 (USD MILLION)
TABLE 200. NORTH AMERICA CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 201. NORTH AMERICA CLINICAL MICROBIOLOGY MARKET SIZE, BY INFECTIOUS DISEASES, 2017-2032 (USD MILLION)
TABLE 202. NORTH AMERICA CLINICAL MICROBIOLOGY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 203. LATIN AMERICA CLINICAL MICROBIOLOGY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 204. LATIN AMERICA CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 205. LATIN AMERICA CLINICAL MICROBIOLOGY MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 206. LATIN AMERICA CLINICAL MICROBIOLOGY MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 207. LATIN AMERICA CLINICAL MICROBIOLOGY MARKET SIZE, BY SOFTWARE, 2017-2032 (USD MILLION)
TABLE 208. LATIN AMERICA CLINICAL MICROBIOLOGY MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 209. LATIN AMERICA CLINICAL MICROBIOLOGY MARKET SIZE, BY IMMUNOASSAYS, 2017-2032 (USD MILLION)
TABLE 210. LATIN AMERICA CLINICAL MICROBIOLOGY MARKET SIZE, BY SEQUENCING, 2017-2032 (USD MILLION)
TABLE 211. LATIN AMERICA CLINICAL MICROBIOLOGY MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 212. LATIN AMERICA CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2017-2032 (USD MILLION)
TABLE 213. LATIN AMERICA CLINICAL MICROBIOLOGY MARKET SIZE, BY BLOOD, 2017-2032 (USD MILLION)
TABLE 214. LATIN AMERICA CLINICAL MICROBIOLOGY MARKET SIZE, BY LEVEL OF AUTOMATION, 2017-2032 (USD MILLION)
TABLE 215. LATIN AMERICA CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 216. LATIN AMERICA CLINICAL MICROBIOLOGY MARKET SIZE, BY INFECTIOUS DISEASES, 2017-2032 (USD MILLION)
TABLE 217. LATIN AMERICA CLINICAL MICROBIOLOGY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 218. AFRICA CLINICAL MICROBIOLOGY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 219. AFRICA CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 220. AFRICA CLINICAL MICROBIOLOGY MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 221. AFRICA CLINICAL MICROBIOLOGY MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 222. AFRICA CLINICAL MICROBIOLOGY MARKET SIZE, BY SOFTWARE, 2017-2032 (USD MILLION)
TABLE 223. AFRICA CLINICAL MICROBIOLOGY MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 224. AFRICA CLINICAL MICROBIOLOGY MARKET SIZE, BY IMMUNOASSAYS, 2017-2032 (USD MILLION)
TABLE 225. AFRICA CLINICAL MICROBIOLOGY MARKET SIZE, BY SEQUENCING, 2017-2032 (USD MILLION)
TABLE 226. AFRICA CLINICAL MICROBIOLOGY MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 227. AFRICA CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2017-2032 (USD MILLION)
TABLE 228. AFRICA CLINICAL MICROBIOLOGY MARKET SIZE, BY BLOOD, 2017-2032 (USD MILLION)
TABLE 229. AFRICA CLINICAL MICROBIOLOGY MARKET SIZE, BY LEVEL OF AUTOMATION, 2017-2032 (USD MILLION)
TABLE 230. AFRICA CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 231. AFRICA CLINICAL MICROBIOLOGY MARKET SIZE, BY INFECTIOUS DISEASES, 2017-2032 (USD MILLION)
TABLE 232. AFRICA CLINICAL MICROBIOLOGY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 233. MIDDLE EAST CLINICAL MICROBIOLOGY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 234. MIDDLE EAST CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 235. MIDDLE EAST CLINICAL MICROBIOLOGY MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 236. MIDDLE EAST CLINICAL MICROBIOLOGY MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 237. MIDDLE EAST CLINICAL MICROBIOLOGY MARKET SIZE, BY SOFTWARE, 2017-2032 (USD MILLION)
TABLE 238. MIDDLE EAST CLINICAL MICROBIOLOGY MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 239. MIDDLE EAST CLINICAL MICROBIOLOGY MARKET SIZE, BY IMMUNOASSAYS, 2017-2032 (USD MILLION)
TABLE 240. MIDDLE EAST CLINICAL MICROBIOLOGY MARKET SIZE, BY SEQUENCING, 2017-2032 (USD MILLION)
TABLE 241. MIDDLE EAST CLINICAL MICROBIOLOGY MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 242. MIDDLE EAST CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2017-2032 (USD MILLION)
TABLE 243. MIDDLE EAST CLINICAL MICROBIOLOGY MARKET SIZE, BY BLOOD, 2017-2032 (USD MILLION)
TABLE 244. MIDDLE EAST CLINICAL MICROBIOLOGY MARKET SIZE, BY LEVEL OF AUTOMATION, 2017-2032 (USD MILLION)
TABLE 245. MIDDLE EAST CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 246. MIDDLE EAST CLINICAL MICROBIOLOGY MARKET SIZE, BY INFECTIOUS DISEASES, 2017-2032 (USD MILLION)
TABLE 247. MIDDLE EAST CLINICAL MICROBIOLOGY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 248. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 249. NATO CLINICAL MICROBIOLOGY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 250. NATO CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 251. NATO CLINICAL MICROBIOLOGY MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 252. NATO CLINICAL MICROBIOLOGY MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 253. NATO CLINICAL MICROBIOLOGY MARKET SIZE, BY SOFTWARE, 2017-2032 (USD MILLION)
TABLE 254. NATO CLINICAL MICROBIOLOGY MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 255. NATO CLINICAL MICROBIOLOGY MARKET SIZE, BY IMMUNOASSAYS, 2017-2032 (USD MILLION)
TABLE 256. NATO CLINICAL MICROBIOLOGY MARKET SIZE, BY SEQUENCING, 2017-2032 (USD MILLION)
TABLE 257. NATO CLINICAL MICROBIOLOGY MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 258. NATO CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2017-2032 (USD MILLION)
TABLE 259. NATO CLINICAL MICROBIOLOGY MARKET SIZE, BY BLOOD, 2017-2032 (USD MILLION)
TABLE 260. NATO CLINICAL MICROBIOLOGY MARKET SIZE, BY LEVEL OF AUTOMATION, 2017-2032 (USD MILLION)
TABLE 261. NATO CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 262. NATO CLINICAL MICROBIOLOGY MARKET SIZE, BY INFECTIOUS DISEASES, 2017-2032 (USD MILLION)
TABLE 263. NATO CLINICAL MICROBIOLOGY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 264. G7 CLINICAL MICROBIOLOGY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 265. G7 CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 266. G7 CLINICAL MICROBIOLOGY MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 267. G7 CLINICAL MICROBIOLOGY MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 268. G7 CLINICAL MICROBIOLOGY MARKET SIZE, BY SOFTWARE, 2017-2032 (USD MILLION)
TABLE 269. G7 CLINICAL MICROBIOLOGY MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 270. G7 CLINICAL MICROBIOLOGY MARKET SIZE, BY IMMUNOASSAYS, 2017-2032 (USD MILLION)
TABLE 271. G7 CLINICAL MICROBIOLOGY MARKET SIZE, BY SEQUENCING, 2017-2032 (USD MILLION)
TABLE 272. G7 CLINICAL MICROBIOLOGY MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 273. G7 CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2017-2032 (USD MILLION)
TABLE 274. G7 CLINICAL MICROBIOLOGY MARKET SIZE, BY BLOOD, 2017-2032 (USD MILLION)
TABLE 275. G7 CLINICAL MICROBIOLOGY MARKET SIZE, BY LEVEL OF AUTOMATION, 2017-2032 (USD MILLION)
TABLE 276. G7 CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 277. G7 CLINICAL MICROBIOLOGY MARKET SIZE, BY INFECTIOUS DISEASES, 2017-2032 (USD MILLION)
TABLE 278. G7 CLINICAL MICROBIOLOGY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 279. BRICS CLINICAL MICROBIOLOGY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 280. BRICS CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 281. BRICS CLINICAL MICROBIOLOGY MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 282. BRICS CLINICAL MICROBIOLOGY MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 283. BRICS CLINICAL MICROBIOLOGY MARKET SIZE, BY SOFTWARE, 2017-2032 (USD MILLION)
TABLE 284. BRICS CLINICAL MICROBIOLOGY MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 285. BRICS CLINICAL MICROBIOLOGY MARKET SIZE, BY IMMUNOASSAYS, 2017-2032 (USD MILLION)
TABLE 286. BRICS CLINICAL MICROBIOLOGY MARKET SIZE, BY SEQUENCING, 2017-2032 (USD MILLION)
TABLE 287. BRICS CLINICAL MICROBIOLOGY MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 288. BRICS CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2017-2032 (USD MILLION)
TABLE 289. BRICS CLINICAL MICROBIOLOGY MARKET SIZE, BY BLOOD, 2017-2032 (USD MILLION)
TABLE 290. BRICS CLINICAL MICROBIOLOGY MARKET SIZE, BY LEVEL OF AUTOMATION, 2017-2032 (USD MILLION)
TABLE 291. BRICS CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 292. BRICS CLINICAL MICROBIOLOGY MARKET SIZE, BY INFECTIOUS DISEASES, 2017-2032 (USD MILLION)
TABLE 293. BRICS CLINICAL MICROBIOLOGY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 294. EUROPEAN UNION CLINICAL MICROBIOLOGY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 295. EUROPEAN UNION CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 296. EUROPEAN UNION CLINICAL MICROBIOLOGY MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 297. EUROPEAN UNION CLINICAL MICROBIOLOGY MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 298. EUROPEAN UNION CLINICAL MICROBIOLOGY MARKET SIZE, BY SOFTWARE, 2017-2032 (USD MILLION)
TABLE 299. EUROPEAN UNION CLINICAL MICROBIOLOGY MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 300. EUROPEAN UNION CLINICAL MICROBIOLOGY MARKET SIZE, BY IMMUNOASSAYS, 2017-2032 (USD MILLION)
TABLE 301. EUROPEAN UNION CLINICAL MICROBIOLOGY MARKET SIZE, BY SEQUENCING, 2017-2032 (USD MILLION)
TABLE 302. EUROPEAN UNION CLINICAL MICROBIOLOGY MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 303. EUROPEAN UNION CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2017-2032 (USD MILLION)
TABLE 304. EUROPEAN UNION CLINICAL MICROBIOLOGY MARKET SIZE, BY BLOOD, 2017-2032 (USD MILLION)
TABLE 305. EUROPEAN UNION CLINICAL MICROBIOLOGY MARKET SIZE, BY LEVEL OF AUTOMATION, 2017-2032 (USD MILLION)
TABLE 306. EUROPEAN UNION CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 307. EUROPEAN UNION CLINICAL MICROBIOLOGY MARKET SIZE, BY INFECTIOUS DISEASES, 2017-2032 (USD MILLION)
TABLE 308. EUROPEAN UNION CLINICAL MICROBIOLOGY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 309. ASEAN CLINICAL MICROBIOLOGY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 310. ASEAN CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 311. ASEAN CLINICAL MICROBIOLOGY MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 312. ASEAN CLINICAL MICROBIOLOGY MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 313. ASEAN CLINICAL MICROBIOLOGY MARKET SIZE, BY SOFTWARE, 2017-2032 (USD MILLION)
TABLE 314. ASEAN CLINICAL MICROBIOLOGY MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 315. ASEAN CLINICAL MICROBIOLOGY MARKET SIZE, BY IMMUNOASSAYS, 2017-2032 (USD MILLION)
TABLE 316. ASEAN CLINICAL MICROBIOLOGY MARKET SIZE, BY SEQUENCING, 2017-2032 (USD MILLION)
TABLE 317. ASEAN CLINICAL MICROBIOLOGY MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 318. ASEAN CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2017-2032 (USD MILLION)
TABLE 319. ASEAN CLINICAL MICROBIOLOGY MARKET SIZE, BY BLOOD, 2017-2032 (USD MILLION)
TABLE 320. ASEAN CLINICAL MICROBIOLOGY MARKET SIZE, BY LEVEL OF AUTOMATION, 2017-2032 (USD MILLION)
TABLE 321. ASEAN CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 322. ASEAN CLINICAL MICROBIOLOGY MARKET SIZE, BY INFECTIOUS DISEASES, 2017-2032 (USD MILLION)
TABLE 323. ASEAN CLINICAL MICROBIOLOGY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 324. GCC CLINICAL MICROBIOLOGY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 325. GCC CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 326. GCC CLINICAL MICROBIOLOGY MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 327. GCC CLINICAL MICROBIOLOGY MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 328. GCC CLINICAL MICROBIOLOGY MARKET SIZE, BY SOFTWARE, 2017-2032 (USD MILLION)
TABLE 329. GCC CLINICAL MICROBIOLOGY MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 330. GCC CLINICAL MICROBIOLOGY MARKET SIZE, BY IMMUNOASSAYS, 2017-2032 (USD MILLION)
TABLE 331. GCC CLINICAL MICROBIOLOGY MARKET SIZE, BY SEQUENCING, 2017-2032 (USD MILLION)
TABLE 332. GCC CLINICAL MICROBIOLOGY MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 333. GCC CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2017-2032 (USD MILLION)
TABLE 334. GCC CLINICAL MICROBIOLOGY MARKET SIZE, BY BLOOD, 2017-2032 (USD MILLION)
TABLE 335. GCC CLINICAL MICROBIOLOGY MARKET SIZE, BY LEVEL OF AUTOMATION, 2017-2032 (USD MILLION)
TABLE 336. GCC CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 337. GCC CLINICAL MICROBIOLOGY MARKET SIZE, BY INFECTIOUS DISEASES, 2017-2032 (USD MILLION)
TABLE 338. GCC CLINICAL MICROBIOLOGY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 339. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 340. CHINA CLINICAL MICROBIOLOGY MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 341. CHINA CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 342. CHINA CLINICAL MICROBIOLOGY MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 343. CHINA CLINICAL MICROBIOLOGY MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 344. CHINA CLINICAL MICROBIOLOGY MARKET SIZE, BY SOFTWARE, 2017-2032 (USD MILLION)
TABLE 345. CHINA CLINICAL MICROBIOLOGY MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 346. CHINA CLINICAL MICROBIOLOGY MARKET SIZE, BY IMMUNOASSAYS, 2017-2032 (USD MILLION)
TABLE 347. CHINA CLINICAL MICROBIOLOGY MARKET SIZE, BY SEQUENCING, 2017-2032 (USD MILLION)
TABLE 348. CHINA CLINICAL MICROBIOLOGY MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 349. CHINA CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2017-2032 (USD MILLION)
TABLE 350. CHINA CLINICAL MICROBIOLOGY MARKET SIZE, BY BLOOD, 2017-2032 (USD MILLION)
TABLE 351. CHINA CLINICAL MICROBIOLOGY MARKET SIZE, BY LEVEL OF AUTOMATION, 2017-2032 (USD MILLION)
TABLE 352. CHINA CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 353. CHINA CLINICAL MICROBIOLOGY MARKET SIZE, BY INFECTIOUS DISEASES, 2017-2032 (USD MILLION)
TABLE 354. CHINA CLINICAL MICROBIOLOGY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 355. UNITED STATES CLINICAL MICROBIOLOGY MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 356. UNITED STATES CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 357. UNITED STATES CLINICAL MICROBIOLOGY MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 358. UNITED STATES CLINICAL MICROBIOLOGY MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 359. UNITED STATES CLINICAL MICROBIOLOGY MARKET SIZE, BY SOFTWARE, 2017-2032 (USD MILLION)
TABLE 360. UNITED STATES CLINICAL MICROBIOLOGY MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 361. UNITED STATES CLINICAL MICROBIOLOGY MARKET SIZE, BY IMMUNOASSAYS, 2017-2032 (USD MILLION)
TABLE 362. UNITED STATES CLINICAL MICROBIOLOGY MARKET SIZE, BY SEQUENCING, 2017-2032 (USD MILLION)
TABLE 363. UNITED STATES CLINICAL MICROBIOLOGY MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 364. UNITED STATES CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2017-2032 (USD MILLION)
TABLE 365. UNITED STATES CLINICAL MICROBIOLOGY MARKET SIZE, BY BLOOD, 2017-2032 (USD MILLION)
TABLE 366. UNITED STATES CLINICAL MICROBIOLOGY MARKET SIZE, BY LEVEL OF AUTOMATION, 2017-2032 (USD MILLION)
TABLE 367. UNITED STATES CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 368. UNITED STATES CLINICAL MICROBIOLOGY MARKET SIZE, BY INFECTIOUS DISEASES, 2017-2032 (USD MILLION)
TABLE 369. UNITED STATES CLINICAL MICROBIOLOGY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 370. JAPAN CLINICAL MICROBIOLOGY MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 371. JAPAN CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT T

Companies Mentioned

  • Abbott Laboratories
  • Agilent Technologies, Inc.
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • bioMérieux SA
  • Bruker Corporation
  • COPAN Group
  • Danaher Corporation
  • DiaSorin S.p.A.
  • Eurofins Scientific SE
  • F. Hoffmann-La Roche Ltd
  • Hardy Diagnostics
  • HiMedia Laboratories
  • Hologic, Inc.
  • Illumina, Inc.
  • Luminex Corporation
  • Merck KGaA
  • Meridian Bioscience
  • Ortho Clinical Diagnostics Holdings plc
  • PerkinElmer, Inc.
  • QIAGEN N.V.
  • QuidelOrtho Corporation
  • Rapid Micro Biosystems, Inc.
  • Seegene Inc.
  • Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • Siemens Healthineers AG
  • Thermo Fisher Scientific Inc
  • Waters Corporation

Table Information

Report AttributeDetails
No. of Pages190
PublishedAugust 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 5.67 Billion
Forecasted Market Value ( USD ) by 2032 $ 9.03 Billion
Compound Annual Growth Rate8.0%
Regions CoveredGlobal
No. of Companies Mentioned28

Related Topics

Related Reports

Clinical Microbiology Market Report by Product, Application, End User, and Region 2026-2034 - Product Image

Clinical Microbiology Market Report by Product, Application, End User, and Region 2026-2034

  • Report
  • 136 Pages
  • Global
From
Clinical Microbiology Market by Product (Instrument (Incubators), Analyzer (Microscope), Reagent, Kits, Media], Disease Area (Respiratory, Gastrointestinal, STD, UTI), End User (Hospitals, Diagnostic Center, Research Institutes) - Global Forecast to 2030 - Product Image

Clinical Microbiology Market by Product (Instrument (Incubators), Analyzer (Microscope), Reagent, Kits, Media], Disease Area (Respiratory, Gastrointestinal, STD, UTI), End User (Hospitals, Diagnostic Center, Research Institutes) - Global Forecast to 2030

  • Report
  • 411 Pages
  • Global
From
Clinical Microbiology Instruments and Reagents - Global Strategic Business Report - Product Image

Clinical Microbiology Instruments and Reagents - Global Strategic Business Report

  • Report
  • 664 Pages
  • Global
From
Clinical Microbiology Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031 - Product Image

Clinical Microbiology Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031

  • Report
  • 180 Pages
  • Global
From
Clinical Microbiology Market Outlook 2026-2034: Market Share, and Growth Analysis by Product Type, Application, End User, Technology - Product Image

Clinical Microbiology Market Outlook 2026-2034: Market Share, and Growth Analysis by Product Type, Application, End User, Technology

  • Report
  • 160 Pages
  • Global
From

About the Clinical Microbiology Market

The Clinical Microbiology market within the In Vitro Diagnostics (IVD) sector is a rapidly growing field. It is focused on the development and production of diagnostic tests and instruments used to detect and identify microorganisms, such as bacteria, viruses, fungi, and parasites. These tests are used to diagnose and monitor infectious diseases, as well as to detect and monitor antibiotic resistance. Clinical Microbiology tests are used in a variety of settings, including hospitals, laboratories, and point-of-care settings. The Clinical Microbiology market is driven by the increasing prevalence of infectious diseases, the emergence of new pathogens, and the need for rapid and accurate diagnosis. Additionally, the increasing demand for personalized medicine and the development of new technologies are expected to drive the market in the future. Some of the major companies in the Clinical Microbiology market include Abbott Laboratories, Becton Dickinson, bioMérieux, Cepheid, Danaher Corporation, Hologic, Qiagen, Roche Diagnostics, Siemens Healthineers, and Thermo Fisher Scientific. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.